Table 2. Five-year relative survival for the 1999–2003 period compared to 5-year relative survival of patients diagnosed in 1994–2003 (‘full cohort') and patients diagnosed in 1999–2003 (‘restricted cohort').
| |
5-year relative survivala |
Change from |
Difference from period 1999–2003 |
|||
|---|---|---|---|---|---|---|
| Cancer | Period 1999–2003 PE (SE) | Full cohort 1994–2003 PE (SE) | Restricted cohort 1999–2003 PE (SE) | 1994–1998 to 1999–2003 | Full cohort 1994–2003 | Restricted cohort 1999–2003 |
| Stomach |
27.7 (0.8) |
26.3 (0.6) |
26.1 (0.8) |
−0.5 |
−1.39 |
−1.61 |
| Oral cavity |
63.3 (1.4) |
64.4 (1.0) |
64.4 (1.4) |
0.3 |
1.09 |
1.16 |
| Oesophagus |
10.9 (1.3) |
10.7 (0.8) |
10.8 (1.2) |
0.2 |
−0.18 |
−0.10 |
| Gallbladder |
11.8 (1.7) |
10.3 (1.2) |
10.4 (1.8) |
0.3 |
−1.53 |
−1.35 |
| Trachea, lung and bronchus |
11.3 (0.4) |
11 (0.3) |
11.2 (0.4) |
0.4 |
−0.36 |
−0.12 |
| Larynx |
57.6 (2.8) |
59.3 (2.0) |
59.3 (2.9) |
0.5 |
1.72 |
1.65 |
| Pancreas |
3.4 (0.4) |
3.7 (0.3) |
4.2 (0.5) |
1.1 |
0.32 |
0.83 |
| Multiple myeloma |
34.7 (1.4) |
34.0 (1.0) |
34.7 (1.4) |
1.3 |
−0.69 |
0.04 |
| Liver |
7.0 (1.0) |
7.1 (0.7) |
7.8 (1.0) |
1.4 |
0.05 |
0.80 |
| Brain and nervous system |
15.2 (0.8) |
15.4 (0.6) |
16.2 (0.9) |
1.7 |
0.18 |
1.03 |
| Cervix |
56.9 (2.5) |
57.2 (1.7) |
58.2 (2.4) |
1.9 |
0.30 |
1.32 |
| Bladder |
73.4 (1.0) |
74.9 (0.7) |
75.9 (1.0) |
2.2 |
1.53 |
2.54 |
| Thyroid |
77.1 (1.8) |
77.2 (1.3) |
78.3 (1.8) |
2.2 |
0.07 |
1.16 |
| Kidney |
57.9 (1.0) |
57.5 (0.7) |
58.6 (1.0) |
2.3 |
−0.38 |
0.72 |
| Leukaemias |
40.8 (1.2) |
41.5 (0.8) |
42.8 (1.1) |
2.7 |
0.65 |
1.93 |
| Skin melanoma |
80.0 (1.2) |
80.5 (0.8) |
82.0 (1.1) |
3.3 |
0.49 |
1.94 |
| Colorectal |
58.2 (0.6) |
58.2 (0.4) |
59.8 (0.6) |
3.4 |
0.00 |
1.60 |
| Corpus uteri |
81.4 (0.9) |
81.6 (0.7) |
83.3 (0.9) |
3.6 |
0.19 |
1.93 |
| Ovarian |
43.6 (1.2) |
39.7 (0.8) |
41.6 (1.1) |
3.7 |
−3.88 |
−1.93 |
| Female breast |
83.2 (0.5) |
84.1 (0.3) |
86.3 (0.5) |
4.7 |
0.89 |
3.03 |
| Hodgkin lymphoma |
61.9 (3.9) |
63.1 (2.7) |
66.4 (3.8) |
6.1 |
1.21 |
4.47 |
| Non-Hodgkin lymphoma |
52.7 (0.9) |
52.7 (0.6) |
56.5 (0.8) |
8.0 |
0.07 |
3.78 |
| Prostate | 81.6 (1.0) | 82.4 (0.7) | 87.8 (0.7) | 16.2 | 0.84 | 6.21 |
Abbreviations: PE=point estimate; SE=standard error.
Finnish Cancer Registry, 23 most common forms of cancer.
a
All survival estimates were age-adjusted to the International Standard Cancer Populations proposed by Corazziari et al (2004).